Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Precision Health Database|Search|PHGKB

Family Health History

Last data update: Dec 08, 2023. (Total: 62301 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 75 Records)

Next

Query Trace: all[original query]>>Guidelines Related[Product Type]
AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review.
Rachel B Issaka et al. Gastroenterology 2023
Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).
Melissa T Carter et al. Journal of medical genetics 2023
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
Schmidt Marjanka K et al. European journal of cancer (Oxford, England : 1990) 2023 18179-91
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer.
Abdel-Razeq Hikmat et al. Breast cancer (Dove Medical Press) 2023 151-10
Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative.
Maurer Marcus et al. The World Allergy Organization journal 2023 16(1) 100729
Considerations on the use of carrier screening testing in human reproduction: comparison between recommendations from the Italian Society of Human Genetics and other international societies.
Capalbo Antonio et al. Journal of assisted reproduction and genetics 2022
Screening, diagnosis and follow-up of Brugada syndrome in children: a Dutch expert consensus statement.
Peltenburg P J et al. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2022
2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea.
Lee Chan Joo et al. Journal of lipid and atherosclerosis 2022 11(3) 213-228
Common data elements to standardize genomics studies in cerebral palsy.
Wilson Yana A et al. Developmental medicine and child neurology 2022
Automated Clinical Practice Guideline Recommendations for Hereditary Cancer Risk Using Chatbots and Ontologies: System Description.
Ritchie Jordon B et al. JMIR cancer 2022 8(1) e29289
Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline.
Kratz Christian Peter et al. Geburtshilfe und Frauenheilkunde 2022 82(1) 42-49
Developing a consensus protocol for genetic testing in frontotemporal dementia.
Greaves Caroline V et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021 17 Suppl 8e052260
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Bratslavsky Gennady et al. Cancer 2021
Evaluation and comparison of hereditary Cancer guidelines in the population.
Ritchie Jordon B et al. Hereditary cancer in clinical practice 2021 19(1) 31
Recent Insights on Genetic Testing in Primary Prostate Cancer.
Kafka Mona et al. Molecular diagnosis & therapy 2021
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
et al. JAMA 2021 325(19) 1965-1977
Screening for High Blood Pressure in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
et al. JAMA 2020 Nov 324(18) 1878-1883
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Adams David et al. Journal of neurology 2020 Jan
Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
et al. Obstetrics and gynecology 2019 Dec 134(6) 1366-1367
Guidelines for the management of hereditary colorectal cancer from the BSG /ACPGBI/UKCGG
British Society Gastroenterology, October 2019
Position Statement on Direct to Consumer Genetic Testing
Royal College of General Practitioners, November 2019
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
, et al. JAMA 2019 0 0. (7) 652-665
Local Coverage Determination (LCD): Genetic Testing for Lynch Syndrome (L34912)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36715)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Diagnostic and Therapeutic Colonoscopy (L36868)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Diagnostic and Therapeutic Colonoscopy (L34213)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36499)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Biomarkers Overview (L35062)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Biomarker Testing (Prior to Initial Biopsy) for Prostate Cancer Diagnosis (L37733)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms (L37810)
The U.S. Centers for Medicare & Medicaid Services
TOP